Fermi Inc (FRMI) stock jumps nearly 10% as class-action filing adds pressure

Fermi Inc (FRMI) stock jumps nearly 10% as class-action filing adds pressure

New York, January 6, 2026, 12:31 (EST) — Regular session

  • Fermi shares rose about 9.8% in midday trade, after swinging more than $1 intraday.
  • Law firms said a securities-fraud class action has been filed, with a March 6 lead-plaintiff deadline.
  • Investors are watching a Jan. 8–9 conference appearance for fresh detail on tenants and financing.

Fermi Inc (FRMI) shares rose nearly 10% in midday trading on Tuesday, lifting the stock to $9.53 from Monday’s close. The stock ranged from $8.62 to $9.68, with volume topping 5.1 million shares.

The rebound comes as a securities-fraud class action has been filed in the U.S. District Court for the Southern District of New York, Gainey McKenna & Egleston said. The complaint alleges Fermi overstated tenant demand for its Project Matador campus and played down the risks of leaning on a single tenant’s $150 million funding commitment. It also cites a Dec. 12 disclosure that the tenant terminated the arrangement, sending the stock down 33.8% that day, the firm said.

Holzer & Holzer said investors who bought Fermi shares in the October 2025 IPO, or between Oct. 1 and Dec. 11, can ask to be appointed lead plaintiff by March 6. A lead plaintiff is the investor chosen to represent other shareholders and direct the case. 1

In a separate notice, Glancy Prongay & Murray said Fermi shares have traded as low as $8.59, about 59% below the $21 IPO price. The stock remains far under its offer level even after Tuesday’s bounce. 2

Fermi raised $682.5 million in its U.S. IPO in late September, selling 32.5 million shares at $21 each, Reuters reported at the time. “There’s no questioning that they’re selling into a lot of demand for AI infrastructure right now,” Renaissance Capital strategist Matt Kennedy said then. 3

Fermi, which trades on Nasdaq and in London under FRMI, says it is building a “behind-the-meter” power-and-data campus in Texas designed to deliver up to 11 gigawatts. Behind-the-meter projects link generation directly to a site, rather than sending power into the public grid. 4

Investors have been looking for signs the project can land binding tenant deals and secure financing as the company scales up construction. Any update on tenant commitments, power delivery timing or capital needs can move the stock, given the company’s limited operating history.

Legal claims can take months to play out and can weigh on a stock, especially for companies that may need fresh capital to fund large buildouts. Delays in tenant signings or funding would sharpen the downside if the project timeline slips.

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
London, Feb 7, 2026, 08:12 GMT — Market closed. Shares of GSK (GSK.L) ended Friday up 0.83% at 2,198 pence, a 52-week high, after the drugmaker said the European Commission approved Nucala for a form of chronic obstructive pulmonary disease (COPD). The stock is up about 17% over the past week and nearly 49% over the past year. 1 With London markets shut for the weekend, investors head into Monday weighing whether the regulatory win is enough to keep the rally going. Respiratory is a core franchise for GSK, and one where it fights for share against big peers including
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Anglo American share price slips as BofA turns neutral after copper outlook cut

Anglo American share price slips as BofA turns neutral after copper outlook cut

7 February 2026
Anglo American shares closed down 0.75% at 3,435 pence Friday after BofA Global Research downgraded the miner to “neutral” and raised its price target to 3,600 pence. Anglo cut its 2026 copper production guidance and warned of continued weakness at De Beers. The company expects $200 million in charges tied to its Chile copper operations in the second half of 2025.
SoFi stock slides below $27.50 deal price after share sale; what investors watch before earnings
Previous Story

SoFi stock slides below $27.50 deal price after share sale; what investors watch before earnings

AbbVie stock nudges higher after Canada clears Maviret — what ABBV investors watch next
Next Story

AbbVie stock nudges higher after Canada clears Maviret — what ABBV investors watch next

Go toTop